# The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)

> **NCT07276802** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Research Insight LLC** · enrollment: 40 (estimated)

## Conditions studied

- Post Cataract Surgery

## Interventions

- **DRUG:** Triamcinolone (Optional)
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT07276802
- **Lead sponsor:** Research Insight LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276802, "The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07276802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*